Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers in connection with the acquisition of Panopticon Software AB by Datawatch Inc.
Mandate

Vinge advises the sellers in connection with the acquisition of Panopticon Software AB by Datawatch Inc.

June 20, 2013

Panopticon had developed a world leading solution to deliver large amounts of real-time unstructured data through a visual discovery paradigm. The acquisition is structured as a share sale and is thus subject to approval by Datawatch’s shareholders and other customary conditions to closing.

Vinge’s team was led by partner Fredrick Sonander.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026